Page 60 - Read Online
P. 60

Page 14 of 29                   Novati et al. Ageing Neur Dis 2022;2:17  https://dx.doi.org/10.20517/and.2022.19

               months, respectively. In tgHD rats, cognitive deficits concern, among others, cognitive flexibility, attention,
               working memory, visuospatial and visual object memory, temporal perception and psychomotor
               performance [210,219,221,249-251] . BACHD rats show impaired reversal learning [111,214,252] , deficits consistent with
                                                                      [253]
               fronto-striatal dysfunction in different short-term memory tests , decreased performance in a decision-
               making task  and impaired associative memory .
                                                        [252]
                         [254]
               Several aspects of social behavior and social cognition are abnormal in HD patients who face problems with
               emotion recognition and awareness as well as theory of mind and, to a certain extent, empathy, which have
               been associated with altered social skills and self-reported social distress [224,255-257] . Transgenic fragment and
               full-length HD mouse models display changes in various social behavior parameters [258-262] . Compared to
               mice,  rats  show  lower  group  aggression   and  are  more  interested  in  the  interaction  with  male
                                                    [4]
                         [18]
               conspecifics . Therefore, free social interaction experiments in males can be better performed in rats. Both
               male and female tgHD rats tend to interact more than wild-type rats with the same sex conspecific starting
               from 1 or 2 months of age, which was interpreted as a low anxiety-like phenotype [210,211] . An automated
               analysis of the BACHD rat behavior in a social interaction test between 2 and 8 months of age demonstrated
                                                              [263]
               alterations in multiple social interaction parameters . Other analyses in the model further revealed
               changes in other areas of social cognition [229,263] . It is difficult to draw direct parallels between social behavior
               parameters measured in humans and rats as social behavior is highly species-specific. Nevertheless, given
               that brain correlates of social behavior are under several aspects comparable in humans and rodents , it is
                                                                                                   [264]
               still reasonable to model main social behavior related functions in rats. Depending on age, in the BACHD
               rats, we find a more aggressive play behavior, decreased tendency to search for or interact with a conspecific
               and a decreased social preference [229,263] , which in part indicates higher anxiety and may altogether be
               representative of a disrupted socio-cognitive function. It would then be important to relate social behavior
               alterations to changes in brain areas relevant to social behavior. In the BACHD rat model, in addition to the
               evidence for an involvement of the amygdala in the modulation of anxiety in a social context , a decreased
                                                                                             [230]
               BDNF gene expression was also reported in the ventral striatum . While the striatum does not have a
                                                                       [263]
               primary social function, it has been suggested to integrate social information into main striatal functions,
                         [265]
               like reward . Future analyses could consider assessing the expression of markers relevant to social
               behavior, such as oxytocin and vasopressin [265,266] , and focus on other brain areas affected in HD, like the
                                                                                         [267]
               hypothalamus, which shows changes in neuronal populations expressing these markers . In HD patients,
               cerebrospinal fluid oxytocin levels were also found to be decreased and to correlate with social cognitive
                    [268]
               scores . As part of social behavior, aggression is often reported in HD patients , but has not been
                                                                                       [255]
               assessed in transgenic rat models. While analyses of aggression could take advantage of well-established
               tests in rats, they may be sensitive to the model strain, which adds to the complexity of a phenotypic profile.

               Altogether the BACHD and tgHD rat models reproduce many features of the HD triad of symptoms. Both
               models present motor and cognitive deficits, and some have been reproduced across studies. These rat
               models also display emotional alterations. The bidirectional anxiety phenotype in the BACHD rat model
               supports further assessments, especially in terms of underlying mechanisms. Furthermore, several
               phenotypes in the HD rat models and in the models of other neurodegenerative disorders have been
               assessed only once. Thus, their repeatability must still be determined. In addition, it remains largely unclear
               to what extent specific phenotypes in animal models and similar symptoms in humans share the same
               biological mechanisms, thereby representing the same kind of impairment.


               PHENOTYPIC/ASPECT-REPLICATING MODELS TO STUDY AD, PD, AND HD
               There is still a vast gap between preclinical studies to effective treatments for patients [269-271] . To date,
               translatability from animal models to humans in terms of treatment efficacy, adverse effects, and tolerability
   55   56   57   58   59   60   61   62   63   64   65